In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy

In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy

Anna-Maria Ciciliani,1,2 Peter Langguth,1 Herbert Wachtel2 1Institute of Pharmacy and Biochemistry, Faculty 09 (Chemistry, Pharmaceutics and Geosciences), Johannes Gutenberg University, Mainz, 2Analytical Development Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany...

Full description

Bibliographic Details
Main Authors: Ciciliani A, Langguth P, Wachtel H
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:International Journal of COPD
Subjects:
throat model
NGI
inhalation
lung deposition
CFD
Respimat
Online Access:https://www.dovepress.com/in-vitro-dose-comparison-of-respimat-inhaler-with-dry-powder-inhalers--peer-reviewed-article-COPD

Internet

https://www.dovepress.com/in-vitro-dose-comparison-of-respimat-inhaler-with-dry-powder-inhalers--peer-reviewed-article-COPD

Similar Items